|
VPS41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.915800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.369600E-01 |
| Normal-vs-Stage2 |
7.016400E-01 |
| Normal-vs-Stage3 |
7.484400E-01 |
| Normal-vs-Stage4 |
2.418000E-01 |
| Stage1-vs-Stage2 |
8.588400E-01 |
| Stage1-vs-Stage3 |
5.914400E-01 |
| Stage1-vs-Stage4 |
1.856760E-01 |
| Stage2-vs-Stage3 |
5.883800E-01 |
| Stage2-vs-Stage4 |
3.165400E-01 |
| Stage3-vs-Stage4 |
5.572000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.693800E-01 |
| Normal-vs-AfricanAmerican |
9.816400E-01 |
| Normal-vs-Asian |
7.223200E-01 |
| Caucasian-vs-AfricanAmerican |
4.545000E-01 |
| Caucasian-vs-Asian |
6.447600E-01 |
| AfricanAmerican-vs-Asian |
8.190000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.880400E-01 |
| Normal-vs-Female |
1.474180E-01 |
| Male-vs-Female |
1.974810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.806400E-01 |
| Normal-vs-Extreme_Weight |
7.252600E-01 |
| Normal-vs-Obese |
4.957400E-01 |
| Normal-vs-Extreme_Obese |
8.362200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.952200E-01 |
| Normal_Weight-vs-Obese |
4.865600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.058800E-01 |
| Extreme_Weight-vs-Obese |
3.425600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.611600E-01 |
| Obese-vs-Extreme_Obese |
5.661600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.352040E-01 |
| Normal-vs-Age(41-60Yrs) |
1.076600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.955600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.494400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.460200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.188800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.189600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.077900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.087950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.345000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.439800E-02 |
| Normal-VS-Type2 PRCC |
1.908240E-01 |
| Normal-VS-KIRP CIMP |
8.521800E-01 |
| Normal-VS-Unclassified PRCC |
1.335450E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.763000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.047600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.154000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.341400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.884000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.832400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.046220E-01 |
| Normal-vs-N1 |
9.084400E-01 |
| Normal-vs-N2 |
4.451000E-01 |
| N0-vs-N1 |
2.406400E-01 |
| N0-vs-N2 |
9.525200E-01 |
| N1-vs-N2 |
6.463200E-01 |
|
|
